How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration

How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration. Pat Furlong, John F. P. Bridges, Lawrence Charnas, Justin R. Fallon, Ryan Fischer, Kevin M. Flanigan, Timothy R. Franson, Neera Gulati, Craig McDonald, Holly Peay and H. Lee Sweeney; Orphanet Journal of Rare Diseases 2015, 10:82 doi:10.1186/s13023-015-0281-2 Published: 24 June 2015

OPEN ACCESS, FULL TEXT PDF